Recent News

• 06.01.2026 - Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
• 06.01.2026 - Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
• 05.22.2026 - Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
• 04.30.2026 - Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
• 04.23.2026 - Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
• 04.22.2026 - Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
• 04.20.2026 - Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
• 04.14.2026 - Greenwich LifeSciences Provides Update on Financing Strategy
• 04.07.2026 - Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
• 03.19.2026 - Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01

Recent Filings

• 03.31.2026 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 01.15.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.14.2026 - 4 Statement of changes in beneficial ownership of securities